These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23716898)

  • 1. Serum drug level-related sodium valproate-induced hair loss.
    Ramakrishnappa SK; Belhekar MN
    Indian J Pharmacol; 2013; 45(2):187-8. PubMed ID: 23716898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent valproate-induced alopecia in patients with mental disorders.
    Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y
    Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate induced increased frequency of micturition and enuresis.
    Gosavi DD; Suman A; Jain M
    Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological laughter following intravenous sodium valproate.
    Jacob PC; Chand RP
    Can J Neurol Sci; 1998 Aug; 25(3):252-3. PubMed ID: 9706729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perampanel-induced hair curling in a patient with epilepsy associated with Pitt Hopkins syndrome.
    Calle-Lopez Y; Kotagal P; Knight EP
    Epileptic Disord; 2019 Oct; 21(5):479-482. PubMed ID: 31638579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced panhypogammaglobulinemia.
    Eom TH; Lee HS; Jang PS; Kim YH
    Neurol Sci; 2013 Jun; 34(6):1003-4. PubMed ID: 22797722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.
    Wheless JW; Vazquez BR; Kanner AM; Ramsay RE; Morton L; Pellock JM
    Neurology; 2004 Oct; 63(8):1507-8. PubMed ID: 15505177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain with valproate or carbamazepine--a reappraisal.
    Easter D; O'Bryan-Tear CG; Verity C
    Seizure; 1997 Apr; 6(2):121-5. PubMed ID: 9153724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproic acid, curly hair and weight gain].
    Bittencourt PR
    Arq Neuropsiquiatr; 1986 Mar; 44(1):78-81. PubMed ID: 3090984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study of first-line valproate monotherapy in focal epilepsy.
    Jedrzejczak J; Kuncíková M; Magureanu S;
    Eur J Neurol; 2008 Jan; 15(1):66-72. PubMed ID: 18042239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disabling Resting Tremors Induced by the Short-term Infusion of Valproate: A Reversible Phenomenon.
    Gupta A; Kushwaha S
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():615. PubMed ID: 30619645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous valproate dosing in neonates.
    Alfonso I; Alvarez LA; Gilman J; Dunoyer C; Yelin K; Papazian O
    J Child Neurol; 2000 Dec; 15(12):827-9. PubMed ID: 11198504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosmetic side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Moeller J; Javed A; Kato K; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2015 Jan; 42():129-37. PubMed ID: 25513768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute chorea caused by valproate in an elderly.
    van de Velde K; Cras P; Helsen G
    Acta Neurol Belg; 2011 Sep; 111(3):220-1. PubMed ID: 22141287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telogen effluvium caused by magnesium valproate and lamotrigine.
    Patrizi A; Savoia F; Negosanti F; Posar A; Santucci M; Neri I
    Acta Derm Venereol; 2005; 85(1):77-8. PubMed ID: 15849002
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous loading of valproate for epilepsy.
    Naritoku DK; Mueed S
    Clin Neuropharmacol; 1999; 22(2):102-6. PubMed ID: 10202606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety, tolerability, and efficacy of magnesium valproate versus sodium valproate in acute seizures.
    Peng X; Yan Y; Chen R; Wang X; Xu X
    Curr Med Res Opin; 2020 Feb; 36(2):271-276. PubMed ID: 31775535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.